Jonathan Berlent - Oct 23, 2020 Form 4 Insider Report for Cure Pharmaceutical Holding Corp. (AVRW)

Signature
/s/ Jonathan Berlent
Stock symbol
AVRW
Transactions as of
Oct 23, 2020
Transactions value $
$0
Form type
4
Date filed
5/27/2021, 07:35 PM
Next filing
Jun 1, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVRW Stock Option Award $0 +62.5K $0.00 62.5K Oct 23, 2020 Common Stock 62.5K $1.20 Direct
transaction AVRW Stock Option Award $0 +188K $0.00 188K Oct 23, 2020 Common Stock 188K $1.20 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable on the basis determined by the equity incentive plan with 14.28% of the option vesting on the first quarter anniversary of vesting start date. For each additional quarter of the participant's service the option will continue to vest until the vested ratio is 100%. This late filing is due to an inadvertent administrative error and not any error of the reporting person.